ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
Clinical utility of LUMIPULSE plasma p-tau217 to identify amyloid positivity among candidates for amyloid-targeting treatments in a real-world cohort.
Ryosuke Shimasaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.